Navigation Links
Arsenic poisoning reactions can be traced to genes

The reaction to a common water pollutant called arsenic may not be the same in all people. Researchers have // pointed out to a gene called CYT19 in people, particularly in children, that may be responsible for varied reactions to the metal called arsenic.

Arsenic exposure had long been associated with health hazards like cancer of the skin, lungs or bladder, circulatory problems, and neurological disorders. It can enter the body through water that gets polluted by toxic wastes of the industries, and leaves the body through the urine after causing as much damage as possible.

The research done by scientists from University of Arizona reports that individual genetic inheritance defines how much the arsenic taken by the body will cause harm to the health. Researchers found that three genes are involved in metabolism of arsenic in the body. The research also showed that children with a mutation of the gene variety CYT19 react to arsenic in a different manner than the adults.

The results of the research can be important as arsenic is often used as a drug to treat cancer. The researchers are hopeful that the new study will lead to new dosages of cancer drugs that will be taking the children’s reactions into account.

Reference: Environmental Health Perspectives, June 200
'"/>




Page: 1

Related medicine news :

1. Chickens Found To Have High Levels of Arsenic
2. Arsenic May Have Been Responsible For The Madness Of King George III Of England
3. Arsenic in drinking water
4. Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life
5. Low Doses Of Arsenic Have Broad Impact On Hormone Activity – Says A Researc
6. Arsenic Compound Effective in Treating Rare Leukemia
7. Arsenic in Chicken Feed may Cause Health Complications
8. Frozen food invite food poisoning
9. Activated charcoal for poisoning treatment
10. Toxic chemicals found in domestic products poisoning newborn babies
11. Pregnant women advised against canned tuna due to mercury poisoning!
Post Your Comments:
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 1VisEn Launches New OsteoSense 28R 29 800 and VivoTag 28R 29 800 Fluorescence Molecular Imaging Agents 6408 2VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 1VerifyNow 28R 29 System Highlighted in POPular Study Comparing Platelet Reactivity Tests 6404 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 1Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 2Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research 6400 3